By D. Xardas. Westmont College. 2018.
Research is funded through traditional revenue streams (grants discount 600mg linezolid overnight delivery, contracts generic linezolid 600mg, philanthropy and licensing revenue) as well as venture capital buy linezolid 600mg free shipping. The result is a verti- cally integrated pipeline that moves from discovery to clinical implementation in a shortened timeframe with reduced costs generic linezolid 600 mg visa. Inova, a nationally recognized Universal Free E-Book Store 618 20 Development of Personalized Medicine comprehensive health care network in the National Capital region and an Ignite founding partner, will play a key role in the Institute’s development by contributing state-of-the art health care facilities focused on disease prevention and personalized medicine. Inova will be the initial clinical arm for the application of new therapeu- tics, diagnostics and devices that target the molecular underpinnings of disease. Ignite will house technologies that include genome sequencing systems, a transcrip- tional proﬁling facility, a proteomics and metabolomics scanning facility, and facili- ties for molecular scanning. The institute’s research specialties will be cancers, neurological and mental health disorders, diabetes and other metabolic diseases, pediatric diseases, and cardiovascular diseases. The institute will conduct research, train new specialists in personalized medicine, and work to translate its discoveries into more precise therapeutics. The training program will be funded and supported through the new Brater Scholarship in Personalized Medicine. The new initiative will support research that uses genetic technologies to develop personalized therapies that could be more effective and efﬁcient for individuals and healthcare providers, and also will fund translational projects and clinical trials. Under the cardiovas- cular initiative, the partners will develop a cardiovascular genetics program and recruit a scientist in the ﬁeld, and will develop a comprehensive program for the study and treatment of heart failure across the lifespan. The neuroscience research program will involve research into a wide range of brain injuries, neurodegenerative disorders, and neurodevelopmental disorders. Although the speciﬁc details of the committee’s tasks remain uncertain, its charge is to review the pub- lished literature to identify what criteria will be appropriate for evaluating tests based on ‘omics tools, including genomics, epigenomics, proteomics, and metabo- lomics tests. After conducting this review, the committee will recommend an evalu- ation process for when these tests are ﬁt for use in designing and stratifying trials and measuring patient response. The group also will identify which criteria are important for the analytical validation, qualiﬁcation, and utilization components of the test evaluation process. After developing those evaluation criteria, the committee then will apply them to three cancer clinical trials conducted by researchers at Duke University. For example, one of these Duke studies involved partnering with Eli Lilly and used Affymetrix gene-expression data with corresponding drug-response data to provide personalized chemotherapy regimens for two types of lung cancer. Although how the committee will apply these criteria has not yet been deter- mined, several approaches may be used. The committee may assess the analytical methods used to generate and validate the predictive models, examine how the source data were used to develop the test and how the predictive models were gen- erated, or evaluate the use of predictive models in clinical trials. Specialty areas for the new lab could include cancer, aging, genetic disorders, metabolic diseases, and others. Space would be dedicated to the translation of new applications such as diag- nostics and computational services into commercial products. Universal Free E-Book Store 620 20 Development of Personalized Medicine Johns Hopkins Center for Personalized Cancer Medicine Research In 2011, The Johns Hopkins Kimmel Cancer Center received a $30 million donation from the Commonwealth Foundation for Cancer Research to fund a new center that focuses on genomics and personalized oncology research. Researchers at the center will study genomic and epigenomic factors that affect leukemia and lung cancer patients’ responses to treatment and develop tests for early detection of various types of cancer. The long-term aim will be the development of individualized immunotherapies such as cancer vaccines and pharmacogenomics- based treatment tools based on genetic discoveries. The clinic has a range of resources, includ- ing genome sequencing, proteomics, and gene expression facilities. Translational programs focus on biomarker discovery, clinical genomics, epigenomics, pharma- cogenomics, and the microbiome. Infrastructure programs include a medical genom- ics facility, biorepositories, bioinformatics resources, as well as bioethics and education/training. The Mayo Clinic Center for Individualized Medicine and Whole Biome are col- laborating to develop microbiome-targeted diagnostics. Mayo Clinic plans to develop a test to enable the early indication of preterm labor. The trial helped physicians at the Mayo Clinic to work out the best way to store a person’s genetic code, develop procedures to explain the information to patients, and direct their medical care. Questions that arise are: who is going to store the information, how is it going to be stored securely, who has access, and what is going to happen to the information that the patient might not want to know about? There are some signiﬁcant ethical and privacy issues, which are more difﬁ- cult to solve than storing the information. The Mayo Clinic launched a pilot study early in 2012 as part of a move towards an era of “proactive genomics” that puts modern genetics at the center of patient care. This is feasible as the cost of sequencing a person’s whole genome has fallen so rapidly that it is now comparable to the price of a single gene test. Another group will be tested for 83 genes that govern how the body metabolizes drugs. Most patients are expected to want to learn only about genetic risk factors that lifestyle changes or medication can inﬂuence. The Mayo Clinic launched a new clinical center in Jacksonville, Florida in 2013 that uses genomic technologies to tailor treatments to individual patients. Genomics scientists, genetic counselors, bioinformatics experts, and bioethicists, will work with physicians to determine whether speciﬁc patients are good candidates for treat- ments guided by genetic testing. This multidisciplinary group will provide consult- ing for cancer patients who have seen standard treatments fail and for patients with “diagnostic odyssey” cases, disorders that are complex or difﬁcult to diagnose but which appear to be genetic in origin. Sinai Medical Center’s Personalized Medicine Research Program In 2007, the Mount Sinai Medical Center in New York received a $12. The research center is studying personalized medicine, and the medical center will use the funds to start “an institution-wide biobank” and a “translational biomedical informatics center. The Institute will bridge the gap between genom- ics research and clinical patient care in the area of personalized medicine. Access and training in these resources will be critical to overcoming current research infrastructure bar- riers that limit our disease-oriented research centers in deciphering the genetic underpinnings of, and developing personalized approaches to, complex diseases. It is comprised of 11 collaborators, mostly from New York City but also from institutions in other states. Through the unique collaboration, scientists and physicians will share clinical and genomic data on a large scale in studies aimed at identifying and validating biomarkers, understanding the molecular basis of diseases, and speeding up the development of new diagnostic and therapeutic technologies. It is using an initial $125 million investment to build the 120,000 square-foot center in Manhattan to begin operations. The partner institutions serve >5 million patients and offer scientists a broad and diverse range of genetic variation that would be difﬁcult to ﬁnd in any other single region. New York City is the largest concentration of medical and academic research anywhere in the world. It provides a place where new products and tests can be developed for a variety of ethnic groups and age groups for which different drugs and approaches might be appropriate. P4Mi was co-founded in 2010 by the Institute for Systems Biology and the Ohio State University Medical Center, which is develop- ing more speciﬁc, cost-effective treatments for patients, creating new technologies and tools that will deﬁne wellness at a deep molecular level, and empowering indi- viduals to take an active role in their health care. P4Mi is now joined by PeaceHealth, a Washington-based not-for-proﬁt Catholic health care system, with major medical centers and laboratories in Alaska, Washington and Oregon with approximately 15,000 employees.
First cheap 600 mg linezolid otc, the width of conﬁdence interval has to be calculated using the Descriptives table obtained from Analyze → Descriptive Statistics → Explore discount linezolid 600mg without a prescription. The numerical values of the mean and the width of the 95% conﬁdence interval are then entered into the SigmaPlot spreadsheet as follows and the commands in Box 3 cheap linezolid 600mg visa. Alternatively order linezolid 600mg, the absolute mean differences between males and females could be pre- sented in a graph. Birth length and head circumference were measured in the same scale (cm) and therefore can be plotted on the same ﬁgure. Birth weight is in different units (kg) and would need to be presented in a different ﬁgure. The decision whether to draw horizontal or vertical dot plots is one of per- sonal choice; however, horizontal plots have the advantage that longer descriptive labels can be included in a way that they can be easily read. If the data are clearly skewed, if outliers have an important effect on the mean value or if the sample size in one or more of the groups is small, say between 20 Comparing two independent samples 81 Body length Head circumference –0. These tests rely on ranking and summing the scores in each group and may lack sufﬁcient power to detect a signiﬁcant difference between two groups when the sample size is very small. The non-parametric test that is equivalent to a two-sample t-test is the Mann–Whitney U test. The Mann–Whitney U test is based on the ranking of measurements from two samples to estimate whether the samples are from the same population. In this test, no assumptions are made about the distribution of the measurements in either group. Null hypothesis: That there is no difference in length of stay between babies who have an infection and babies who do not have an infection. Variables: Outcome variable = length of stay (continuous) Explanatory variable = infection (categorical, binary) Descriptive statistics and the distribution of the outcome variable length of stay in each group can be inspected using the commands shown in Box 3. The skewness statistics are all above 2 and the kurtosis statistics are also high, indicating that the data are peaked and are not normally distributed. Case Processing Summary Cases Infection Valid Missing Total N Per cent N Per cent N Per cent Length of stay No 80 94. The histograms show that both distributions are positively skewed with tails to the right. The Q–Q plot for each group does not follow the line of normality and is signiﬁcantly curved. The normality statistics for babies with an infection and babies without an infection are summarized in Table 3. For both groups, the data are positively skewed and could possibly be transformed to normality using a logarithmic transformation. Without transformation, the most appro- priate test for analysing length of stay is a rank-based non-parametric test, which can be obtained using the commands shown in Box 3. Comparing two independent samples 85 Normal Q–Q plot of length of stay for infect = No 7. For illustrative purposes, a random subset of 20 cases with valid length of stay is shown in Table 3. Similarly, the four data points of 17 share the ranks from 17 to 20 and are ranked at 18. Decision Independent- The distribution of Length of stay is Samples Reject the 1 the same across categories of Mann-. Non-parametric tests By double clicking on the Hypothesis Test Summary table, the Model Viewer screen will open. The Model View has a two panel views, with the Hypothesis Test Summary table shown on the left hand side, referred to as the Main View. On the right side, the linked Auxiliary View is displayed which shows the following population pyramid chart and test table. The chart displays back-to-back histograms for each category of the group, that is, ‘No’ infection and ‘Yes’ infection. The number of cases in each group and the mean rank of each group are also reported. The mean ranks provide an indication of the direction of effect but because the data are ranked, the dimension is different from the original measurement and is therefore difﬁcult to communicate. Independent-Samples Mann-Whitney U Test Infection No Yes 300 300 N = 80 N = 52 Mean Rank = 58. The asymptotic signiﬁcance value is reported when the sample size is large, say more than 30 cases. The difference between the groups could be reported in a table as shown in Table 3. Another approach to non-normal data is to divide the outcome variable into cat- egorical centile groups as discussed in Chapter 8. Decision about whether to use non-parametric tests, to transform the variable or to categorize the values requires careful consideration. The decision should be based on the size of the sample, the effectiveness of the transformation in normalizing the data and the ways in which the relationship between the explanatory and outcome variables is best presented. Adventure education and outward bound: out-of-class experiences that make a lasting difference. This test is used when two continuous variables are related because they are collected from the same participant at different times, from different sites on the same person at the same time or from cases and their matched controls. When using a paired t-test, the variation between the pairs of measurements is the most important statistic and the variation between the participants, as when using a two-sample t-test, is of little interest. The null hypothesis for a paired t-test is that the mean of the differences between the two related measurements is equal to zero, that is, no difference. Thus, the number of rows in the data sheet is the same as the number of participants when the outcome variable is measured more than once for each participant or is the number of participant-pairs when cases and controls are matched. When each participant is measured on two or more occasions, the sample size is the number of participants. In a matched case–control study, the number of case–control pairs is the sample size and not the total number of participants. For this reason, withdrawals, loss of follow-up data and inability to recruit matched controls reduce both power and the generalizability of the paired t-test because participants with missing paired values or cases who are not matched with controls are excluded from the analyses. Treating paired or matched measurements as independent samples will artiﬁcially inﬂate the sample size and lead to inaccurate analyses. The decision of whether to use a one- or two-tailed test must be made when the study is designed. If a one-tailed t-test is used, the null hypothesis is more likely to be rejected than if a two-tailed test is used (Chapter 3). In general, two-tailed tests should always be used unless there is a good reason for not doing so and a one-tailed test should only be used when the direction of effect is speciﬁed in advance. Does the head circumference of babies increase signiﬁcantly in a 2-month growth period? Variables: Outcome variables = weight, length and head circumference measured at 1 month of age and 3 months of age (continuous) 4.
Zuckier (2004) in a paper presented at The Radiological Society of North America annual meeting in Chicago sug- gested the following periods for different radionuclides for the patients to carry the card discount linezolid 600 mg on-line. One important factor is the graphic images of the devastating effects of the atomic bombs detonated in Hiroshima and Nagasaki in 1945 discount 600mg linezolid fast delivery, and to a lesser extent buy cheap linezolid 600mg, the images of the Chernobyl reactor accident in 1986 cheap 600mg linezolid mastercard. The most noticeable effects of these incidents are death of living species and destruction of property at the site of the explosion and its immediate vicin- ity. Because of these images, many people associate radiation exposure with adverse health effects and death. These images are ﬁrmly embedded in the minds of the public causing perpetual fear of radiation. Another ﬂashpoint in creating radiation phobia in the public’s mind is the knowledge of assumption that any level of ionizing radiation is dan- 264 15. Psychological warfare with anecdotal rhetoric among the rival countries possessing nuclear weapons also creates fear of radiation among the public. Dreading effects of radiation on children and future offspring, and long-term damage to property are major concerns of the public. Furthermore, the media often play a role in exacerbating the problem of exposure from radiation accidents. Def- initely, nuclear detonation causes an instantaneous devastating effect on the population and property, and so can be reason for fear and panic. But the long-term effects of low doses of radiations, even from the fallout of the atomic bombs in Japan and Chernobyl accident, have been shown to be rel- atively small. The average individual lifetime dose from the Chernobyl fallout is estimated to be 0. By comparison, the worldwide average annual dose rate of natural radiation an individual receives on earth is 220mrem (2. In the United States, an individual receives an annual dose of about 300mrem (3mSv) including radon and a lifetime dose of 21rem (210mSv). These values are even ten times higher in some regions in India and Brazil, and yet incidence of excess cancer is not shown to be higher in these places. People face risk of cancer, injuries, and even death from day-to-day living activities, such as driving, smoking cigarettes, drinking alcohol, eating food, and breathing air, in addition to hazardous job-related activities. If the population is exposed to 1rem (10mSv) of radiation exposure, the risk of cancer increases only by 0. Based on these arguments, it can be said that although nuclear explosions can be a cause for grave concern, low-dose radiations from medical facilities, natural back- ground, and the like, are fairly safe relative to the hazards of different living activities, and the risk from such radiation exposure is small. People knowledge- able in radiation should talk to laymen explaining the relatively small risk of low-level radiations compared to many other day-to-day living activities. The media should play an important role in communicating this informa- tion to the public. Radiation experts should hold regular public seminars to explain the minimal risk of low-level radiation. Radiation-related profes- sional organizations such as the Society of Nuclear Medicine, The Radio- logical Society of North America, Health Physics Society, and American Association of Physicists in Medicine should undertake appropriate approaches of communication with the public to shed their concern and fear of radiation. What are the two most common chromosome aberrations that are responsible for carcinogenesis? Elucidate the mechanisms of sublethal damage repair and potentially lethal damage repair. What is the recent value of cancer death attributable to radiation exposure in Japanese survivors of the atomic bomb? What are the different dose-response models preferred for solid tumors and leukemia? What are the recommended steps one should take in the case of the explosion of a dirty bomb? Homeland Security monitors radioactivity for dirty bombs at strategic points of commuting. The patients undergoing nuclear studies are given cards by the hospitals to provide proof of radioactive exam- inations. References and Suggested Readings 267 References and Suggested Readings American Cancer Society. Sensitivity of personal homeland security radiation detectors to medical radionuclides and implications for counseling of nuclear medicine patients. To minimize their risks, international and national organizations have been established to set guide- lines for safe handling of radiations. They make recommendations and guidelines for radiation workers to follow in handling radiations. The regulations pertinent to the practices of nuclear medicine are brieﬂy described here. On the other hand, naturally occurring and accelerator-produced radionuclides are regulated by indi- vidual states. Sources of Radiation Exposure The population at large receives radiation exposure from various sources such as natural radioactivity, medical procedures, consumer products, and occupational sources. The estimates of annual effective dose equivalents from different radiation sources to the U. Excluding radon exposure, the average exposure from natural background consisting of cos- mic radiations, terrestrial radiations, and so on amounts to about 100mrem (1mSv)/year. For example, the annual cosmic ray exposure in cities such as Denver is about 50mrem (0. It varies from about 16mrem (160mSv)/year in the Atlantic ocean to 63mrem (630mSv)/year in the Rockies with an average of 28mrem (280mSv)/year. Radionuclides ingested through food, water, or inhalation include 40K and decay products of thorium and uranium, particularly 210Po, and contribute about 39mrem (390mSv) annually. Medical procedures contribute the highest exposure of all man-made ra- diation sources. The most exposure comes from diagnostic radiographic procedures with about 39mrem (390mSv) annually compared to 14mrem (140mSv) for nuclear medicine procedures. Consumer products such as tobacco, water supply, building materials, agricultural products, and television receivers contribute to radiation expo- Table 16. Sources Average annual effective dose equivalent in mrem (mSv) Natural sources Radon 200 (2. The total exposure from consumer products varies between 5 and 13mrem (50 and 130mSv)/year. Occupational exposure is received by the workers in reactor plants, coal mines, and other industries using radionuclides. Nuclear power plants around the country release small amounts of radionuclides to the environment, which cause radiation exposure to the population. Such general licenses are given to physicians, veterinarians, clin- ical laboratories, and hospitals only for in vitro tests, not for the use of by-product material in humans or animals. The amount of 14C and 3H can be obtained in units of 10mCi (370kBq) and 20mCi (740kBq), respectively. The former types of speciﬁc licenses are typically given to commercial manufacturers.
Disease prevalence in a certain region contrib- utes to the patient’s pretest probability generic 600 mg linezolid fast delivery. However linezolid 600 mg without prescription, other factors such as the patient’s age cheap 600mg linezolid with amex, clinical history and risk factors for the disease in question are also important in deter- mining pretest probability discount linezolid 600 mg with amex. Armed with an estimated pretest probability and a positive test with a known likelihood ratio, the clinician can estimate a posttest probability of dis- ease. Generally, diagnostic tests are most useful in patients with a medium pretest proba- bility (25–75%) of having a disease. For example, in a patient with a low pretest probability of disease, a positive test can be misleading in that the patient’s posttest prob- ability of disease is still low. The same applies for a patient with a high pretest probability of disease with a negative test: the negative test usually does not rule out disease. It is therefore incumbent upon the physician to have a rough estimate of the pretest probabil- ity of disease, positive likelihood ratio of the diagnostic test, and negative likelihood ratio of the diagnostic test prior to ordering the test. This is the difference in mortality (or another endpoint) between the treatment and the placebo arms. The test should not have been ordered in the ﬁrst place and is an example of defensive medicine. Any further testing could expose the patient to undue invasive testing and further anxiety. Her aspirin should be stopped; she should be reassured; other causes of chest pain in a healthy young woman should be evaluated. This may be partly re- lated to the observation that physicians are less likely to suspect heart disease in women with chest pain and are less likely to perform diagnostic and therapeutic procedures in women. Cholesterol-lowering drugs are as effective in women as in men for primary and secondary prevention of coronary heart disease. Overall, women receive fewer risk modiﬁcation interventions than men, likely because of the perception that they are at lower risk of coronary heart disease. Yet clinical trials have not shown convincing ef- ﬁcacy for respiratory infections. Ginkgo biloba is being evaluated in a large trial to evalu- ate its efﬁcacy in reducing the rate of onset or progression of dementia. Only glucosamine/ chondroitin sulfate have proven beneﬁt in a large multicenter controlled trial. Therefore, from a pharmaco- kinetic standpoint, the patient may not achieve full efﬁcacy of the antihypertensive agent until 10 days into therapy. There is no reason to add a second agent or switch to another agent until completing a trial of adequate duration on the current agent. Physical and laboratory examinations reveal evidence of worsening cirrhosis and opiate toxicity. Hepatic encephalopathy and sub- acute bacterial peritonitis are considerations in the cirrhotic patient with impaired men- tal status. However, the patient has no discernible ascites and no evidence of hepatic encephalopathy on examination. The focus should be on reducing centrally acting thera- pies such as morphine, rather than adding another medicine such as haloperidol. The most common presenting symptom of this disorder is sensory changes that affect pain and temperature. Physical examination can have a multitude of ﬁndings, depending on the degree of tissue damage. The prognosis is most favorable when the presenting area is warm and has a normal color. Treatment is with rapid rewarming, which usually is ac- complished with a 37 to 40°C (98. The period of rewarming can be intensely painful for the patient, and often narcotic analgesia is warranted. If the pain is intolerable, the temperature of the water bath can be dropped slightly. Compartment syndrome can develop with rewarming and should be investigated if cyanosis persists af- ter rewarming. No medications have been shown to improve outcomes, including hep- arin, steroids, calcium channel blockers, and hyperbaric oxygen. In the absence of wet gangrene or another emergent surgical indication, decisions about the need for amputa- tion or debridement should be deferred until the boundaries of the tissue injury are well demarcated. After recovery from the initial insult, these patients often have neuronal in- jury with abnormal sympathetic tone in the extremity. Other remote complications in- clude cutaneous carcinomas, nail deformities, and, in children, epiphyseal damage. This disorder is the most common type of incontinence in the elderly, both males and females. In females there is no need to do further testing in a patient with long-standing incontinence; however, in males urethral obstruction is often coexistent, and urodynamic testing is indicated to in- vestigate this possibility. An abrupt onset of symptoms or associated suprapubic pain in either sex should prompt cystoscopy and urine cytologic testing to evaluate for bladder stones, tumor, or infection. If drugs are imperative, oxybutynin or tolterodine can be tried with close follow-up to ensure that urinary retention does not occur. Indeed, pa- tients with heart failure, chronic kidney disease, or hyponatremia should not take this medication. Indwelling catheters are rarely indicated for this disorder; instead, external collection devices or protective pads or undergarments are favored. Drug clearance is altered because of decreased renal plasma ﬂow and glomerular ﬁltration as well as decreased hepatic clearance. Furthermore, the vol- ume of distribution of many drugs is decreased with a drop in total body water. However, in older persons there is a relative increase in fat, which will lengthen the half-life of fat-soluble medications. Serum albumin levels decline in general in the elderly, particularly in the hospi- talized and sick population. As a result, drugs that are primarily protein-bound, such as war- farin and phenytoin, will have higher free or active levels at similar doses. Care must be taken in interpreting total serum levels for these drugs because a low total level may be accompa- nied by a normal free level and thus be appropriately therapeutic. Adverse drug reactions are common in the elderly and are related to altered drug sensitivity, impaired renal or he- patic clearance, impaired homeostatic mechanisms, and drug interactions. The association may be due to the increased risk of falling (related to sedation) in a popula- tion with a high prevalence of osteoporosis. This association may also be true for other drugs with sedative properties such as opioids or antipsychotics. Conversely, elderly patients often display decreased sensitivity to beta blockers.
9 of 10 - Review by D. Xardas
Votes: 82 votes
Total customer reviews: 82